News

no news in this list.

 

Fostering the development of medicinal products for paediatric use – consultation on the partial revision of the Patents Ordinance

The research and development of medicinal products specifically for children should be fostered. In order to achieve this, the Patents Act has been revised within the scope of the revision to the Therapeutic Products Act. Pharmaceutical companies that carry out paediatric studies can be granted a six-month extension to a supplementary protection certificate that has already been granted or granted a newly created paediatric supplementary protection certificate. Parliament adopted the revision to the Therapeutic Products Act and with it, the partial revision of the Patents Act on 18 March 2016. The Federal Department of Justice and Police submitted for consultation the required amendment to the Patents Ordinance on 22 June 2017. The cantons, parties and other interested stakeholders can submit their comments by 20 October 2017.